Skip to main content

Danimer Scientific, Inc (DNMR)

NYSE: DNMR · Delayed Price · USD
14.96
-0.01 (-0.07%)
Pre-market:Oct 26, 2021 5:13 AM EDT
14.97
0.24 (1.63%)
At close: Oct 25, 4:00 PM

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018
Revenue
47.3332.3430.45
Revenue Growth
46.34%6.21%-
Cost of Revenue
35.8821.2419.21
Gross Profit
11.4611.1111.25
Selling, General & Admin
19.3416.037.3
Research & Development
7.855.485.14
Other Operating Expenses
-0.017.72-4.36
Operating Expenses
27.1929.238.07
Operating Income
-15.73-18.123.17
Interest Expense / Income
2.433.483.23
Other Expense / Income
-9.3-6.17-0.32
Pretax Income
-8.85-15.430.26
Income Tax
04.090.05
Net Income
-8.85-19.510.21
Net Income Common
-8.85-19.510.21
Shares Outstanding (Basic)
30252
Shares Outstanding (Diluted)
30253
Shares Change
16.72%756.21%-
EPS (Basic)
-0.30-0.770.09
EPS (Diluted)
-0.30-0.770.07
Free Cash Flow Per Share
-1.76-1.481.33
Gross Margin
24.21%34.34%36.92%
Operating Margin
-33.23%-56.03%10.42%
Profit Margin
-18.70%-60.33%0.68%
Free Cash Flow Margin
-109.98%-115.50%10.29%
Effective Tax Rate
0.00%-26.48%19.69%
EBITDA
-1.3-7.897.03
EBITDA Margin
-2.75%-24.38%23.08%
EBIT
-6.43-11.953.49
EBIT Margin
-13.58%-36.96%11.46%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).